Zobrazeno 1 - 10
of 4 514
pro vyhledávání: '"Variceal bleeding"'
Autor:
Andrea Silva, David Perdigoto, Diogo Feijó, João Lucas, Tiago Oliveira, Paulo Donato, Pedro Narra Figueiredo
Publikováno v:
GE: Portuguese Journal of Gastroenterology, Pp 1-7 (2024)
Introduction: Several studies have highlighted the potential benefits of early prophylactic transjugular intrahepatic portosystemic shunt (preemptive TIPS) placement in reducing morbidity and mortality following variceal bleeding (VB). Baveno VII rec
Externí odkaz:
https://doaj.org/article/e45d6df681254ec0ab45b70966497df1
Autor:
A. Yu. Anisimov, Yu. A. Anisimov
Publikováno v:
Неотложная медицинская помощь, Vol 13, Iss 3, Pp 427-435 (2024)
AIM OF THE STUDY. Comparative clinical analysis of the efficacy of terlipressin and octreotide as additional drug therapy to mechanical hemostasis with nitinol stent in patients with liver cirrhosis complicated by bleeding from esophageal varices ref
Externí odkaz:
https://doaj.org/article/9681d422e863449da2f6c737f0ef8e52
Publikováno v:
Open Life Sciences, Vol 19, Iss 1, Pp 581-9 (2024)
The aim of the present study is to explore the potential prediction value of neutrophil-to-lymphocyte ratio (NLR) or peripheral blood platelet-to-lymphocyte ratio (PLR) for rebleeding in patients with esophagogastric variceal bleeding (EVB). We have
Externí odkaz:
https://doaj.org/article/0322501333b245b7b28337e58c02fa7a
Publikováno v:
Journal of Inflammation Research, Vol Volume 17, Pp 5211-5221 (2024)
Hao-Huan Tang,1,* Lin-Feng Zhou,2,3,* Chun-Xin Wang,4,* Yang Zha,4 Chen Fan,1 Bin-Yan Zhong,2 Xiao-Li Zhu,2 Wei-Dong Wang1 1Department of Interventional Radiology, The Affiliated Wuxi People’s Hospital of Nanjing Medical University, Wux
Externí odkaz:
https://doaj.org/article/e5fbae392f1d4bc8994fd023a351b087
Publikováno v:
Saudi Journal of Medicine and Medical Sciences, Vol 12, Iss 3, Pp 266-269 (2024)
Sarcoidosis is a disease of unknown etiology, characterized by noncaseating granulomas. Generally, the condition primarily manifests in the lungs. Extrapulmonary involvement is common, but localization in the gastrointestinal system is rare. Here, we
Externí odkaz:
https://doaj.org/article/e4976d46ad3e441cbb0dfe99b2957c14
Autor:
Yu. V. Khoronko, E. V. Kosovtsev, R. V. Korobka, A. E. Sarkisov, E. Yu. Khoronko, I. A. Ashimov, E. V. Tadieva
Publikováno v:
Кубанский научный медицинский вестник, Vol 31, Iss 3, Pp 57-72 (2024)
Background. Variceal esophageal-gastric bleeding is considered to be a life-threatening complication of portal hypertension in patients with cirrhosis. In some cases, only portosystemic shunt can serve as a life-saving intervention for the patient.Ai
Externí odkaz:
https://doaj.org/article/5c4109a80fe542f6a17e70d73de1f9e9
Publikováno v:
Heliyon, Vol 10, Iss 19, Pp e37731- (2024)
Objectives: Esophagogastric variceal bleeding (EVB) is one of the main causes of cirrhosis-related deaths, and endoscopic therapy is the first-line treatment of choice. However, the efficacy of prophylactic endotracheal intubation (PEI) before endosc
Externí odkaz:
https://doaj.org/article/31889f97abb24bf49845cf7ceb085715
Autor:
Roberta Maselli, Leonardo Da Rio, Mauro Manno, Paola Soriani, Gianluca Andrisani, Francesco Maria Di Matteo, Carlo Fabbri, Monica Sbrancia, Cecilia Binda, Alba Panarese, Fulvio D'Abramo, Teresa Staiano, Stefano Rizza, Renato Cannizzaro, Stefania Maiero, Vittoria Stigliano, Germana de Nucci, Gianpiero Manes, Marco Sacco, Antonio Facciorusso, Cesare Hassan, Alessandro Repici
Publikováno v:
Endoscopy International Open, Vol 12, Iss 10, Pp E1220-E1229 (2024)
Externí odkaz:
https://doaj.org/article/74777d762ce84546adb8f628df5c4797
Publikováno v:
Gastroenterology Insights, Vol 15, Iss 2, Pp 396-408 (2024)
Background: Acute variceal bleeding (AVB) is a critical complication of portal hypertension, contributing significantly to mortality worldwide. Pharmacological interventions, including terlipressin and octreotide, have evolved to manage AVB, yet cons
Externí odkaz:
https://doaj.org/article/fe41f11209514798bc17822f0246188e
Publikováno v:
Liver Cancer, Pp 1-11 (2024)
Introduction: The combination of atezolizumab/bevacizumab has emerged as an effective first-line treatment for advanced hepatocellular carcinoma (HCC). However, this therapy is potentially associated with bleeding complications, warranting a comprehe
Externí odkaz:
https://doaj.org/article/e421a5e6c3674506bd9814db22e3d35c